Table 4.

Adverse responses to chemotherapy and its association with the expression of miR‐145, miR‐185, miR‐381, and miR‐195 in patients with GC who underwent neoadjuvant chemotherapy

	miR‐145	miR‐185	miR‐381	miR‐195
Bone marrow suppression
Yes (31)	0.2912 ± 0.0743	0.2288 ± 0.1014	0.4648 ± 0.1765	0.2499 ± 0.1043
No (89)	0.4562 ± 0.1609	0.2361 ± 0.1305	0.4929 ± 0.2011	0.2603 ± 0.1036
t	−5.4976	−0.2829	−0.6905	−0.4805
P	<.001	.7778	.4913	.6318
Gastrointestinal reaction
Yes (18)	0.4515 ± 0.1610	0.2624 ± 0.0917	0.4586 ± 0.1741	0.2689 ± 0.0993
No (102)	0.4069 ± 0.1604	0.2293 ± 0.1278	0.4904 ± 0.1985	0.2556 ± 0.1045
t	1.0870	1.0505	−0.6373	0.5014
P	.2792	.2957	.5252	.6171
Peripheral nerve injury
Yes (38)	0.4490 ± 0.1709	0.2515 ± 0.1015	0.4678 ± 0.1845	0.2528 ± 0.1019
No (82)	0.3971 ± 0.1539	0.2262 ± 0.1320	0.4939 ± 0.1998	0.2599 ± 0.1047
t	1.6589	1.0460	−0.6816	−0.3485
P	.0998	.2977	.4968	.7281